December 11, 2023

PLCOm2012 models have higher sensitivity than USPSTF criteria, with no difference by Indigenous classification Two versions of the PLCOm2012 risk‐prediction model (based on the 2012 Prostate, Lung, Colorectal, and Ovarian [PLCO] Cancer Screening Trial), with and without a predictor for race, have high sensitivities for lung cancer, according to a study published online Oct. 9...

The role of cholesterol pathway biomarkers in multiple sclerosis is not fully understood. This article makes the case that these biomarkers may correlate with cognitive impairment. Cholesterol pathway biomarkers are associated with breakdown of the blood-brain barrier, lesions, and neurodegeneration in patients with multiple sclerosis (MS). Cognitive impairment is common in these patients, and is...